The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence
An understanding of the origin of cancer is critical for cancer prevention and treatment. Complex biological mechanisms promote carcinogenesis, and there is increasing evidence that pregnancy‐related exposures influence foetal growth cell division and organ functioning and may have a long‐lasting im...
Saved in:
Published in: | Journal of internal medicine Vol. 283; no. 5; pp. 430 - 445 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
Blackwell Publishing Ltd
01-05-2018
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | An understanding of the origin of cancer is critical for cancer prevention and treatment. Complex biological mechanisms promote carcinogenesis, and there is increasing evidence that pregnancy‐related exposures influence foetal growth cell division and organ functioning and may have a long‐lasting impact on health and disease susceptibility in the mothers and offspring. Nulliparity is an established risk factor for breast, ovarian, endometrial and possibly pancreatic cancer, whilst the risk of kidney cancer is elevated in parous compared with nulliparous women. For breast, endometrial and ovarian cancer, each pregnancy provides an additional risk reduction. The associations of parity with thyroid and colorectal cancers are uncertain. The timing of reproductive events is also recognized to be important. Older age at first birth is associated with an increased risk of breast cancer, and older age at last birth is associated with a reduced risk of endometrial cancer. The risks of breast and endometrial cancers increase with younger age at menarche and older age at menopause. The mechanisms, and hormone profiles, that underlie alterations in maternal cancer risk are not fully understood and may differ by malignancy. Linking health registries and pooling of data in the Nordic countries have provided opportunities to conduct epidemiologic research of pregnancy exposures and subsequent cancer. We review the maternal risk of several malignancies, including those with a well‐known hormonal aetiology and those with less established relationships. The tendency for women to have fewer pregnancies and at later ages, together with the age‐dependent increase in the incidence of most malignancies, is expected to affect the incidence of pregnancy‐associated cancer.
This is an article from the symposium: “Think Tank” Meeting ‐ Nordic Countries Linked Birth and Cancer Registries Cohort Project |
---|---|
ISSN: | 0954-6820 1365-2796 1365-2796 |
DOI: | 10.1111/joim.12747 |